Moberg Pharma AB (Formerly known as Moberg Derma) Year-end Report 2014

Regulatory News:

Moberg Pharma AB (STO:MOB)

SUCCESSFUL FOURTH QUARTER AND THE FIRST PROFITABLE FULL YEAR

PERIOD (JAN-DEC 2014)

· Revenue MSEK 200.2 (157.4)

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC